Journey Medical (DERM) Earnings Date & Reports

Journey Medical Corp is a commercial stage pharmaceutical company focused on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions... Show more

Industry: #Biotechnology

Get AI intraday signals

A.I. Advisor

published Earnings

DERM is expected to report earnings to rise 43.75% to -17 cents per share on March 20

Journey Medical DERM Stock Earnings Reports

Q4'24

Est.

$-0.17

Q3'24

Beat

by $0.05

Q2'24

Missed

by $0.03

Q1'24

Missed

by $0.31

Q4'23

Beat

by $0.83

The last earnings report on November 12 showed earnings per share of -11 cents, beating the estimate of -17 cents. With 64.59K shares outstanding, the current market capitalization sits at 73.35M.

View a ticker or compare two or three

Compare

DERM